HC3 Transformation Series Event: Decentralized Clinical Trials
Time & Location
About the Event
Read the recap and watch the recording here.
On March 9, HC3 collaborated with Ziegler to host a discussion exploring the benefits of decentralized clinical trials. In this conversation, experts provided insight into how they are developing technologies and implementing solutions-based approaches to support clinical trials being hosted outside of their normal structures thanks to technology advancements.
Meghan Phillipp, Executive Director, HC3
Grant Chamberlain, Managing Director, Healthcare Corporate Finance, Ziegler
Patrick Walsh, Managing Director, Healthcare Corporate Finance, Ziegler
Jennifer Junis, Senior Vice President, OnCall Digital Health, OSF Health Healthcare
Melissa Nezos, Vice President, Clinical Operations, Firma Clinical Research
John Reites, Chief Executive Officer, THREAD